Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thyroid Cancer Metastatic × lenvatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Carcinoma, Hepatocellular 39 Liver Neoplasms 4 Cholangiocarcinoma 3 Advanced Biliary Tract Cancer 3 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Biliary Tract Neoplasms 2 Thyroid Neoplasms 1 Thyroid Cancer Metastatic 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Potentially Resectable Locally Advanced Malignant Tumors of Biliary System 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Liver Cirrhosis 1 Klatskin Tumor 1 Hepatoblastoma 1 HER2-negative Advanced Gastric Cancer 1 Gastric Cancer Metastatic to Liver 1 Gallbladder Neoplasms 1 First-line Treatment 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Biliary Tract Tumor 1 Advanced Primary Liver Cancer 1 Adenocarcinoma 1

Interventions

lenvatinib 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732495 2022-03-29

LENVOS

Centre Leon Berard

Phase 2 Unknown

EndocrineHead & Neck

Thyroid Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡